Epstein Secrets

His performances have been described as "vital, rich-hued solo playing" by the New York Times, and "a

icated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics. Dr. Venter is also Founder and CEO of Synthetic Genomics Inc (Sal), a privately held company dedicated to commercializing genomic-driven solutions to address

mokes included in this statement where indicated rich the nunlier 'I,' LES FhancialServtes has relied

ty repented vats no question, or when a value would be highy speadatime due to tie nature c4 the murky. - When neither an Muer, general partner or Venter estimated value nor a thed-paly estimated vats is market the maturate security Mite dderent from its ;ached price. - • Daributicns to date' may i

. His performances have been described as “vital, rich-hued solo playing” by the New York Times, and “a

edicated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics. Dr. Venter is also Founder and CEO of Synthetic Genomics Inc (SGI), a privately held company dedicated to commercializing genomic-driven solutions to address gl